LINC01506: A Potential Drug Target and Biomarker (G101927015)

Target Name: LINC01506

NCBI ID: G101927015

LINC01506

Other Name(s): long intergenic non-protein coding RNA 1506 | Long intergenic non-protein coding RNA 1506

LINC01506: A Potential Drug Target and Biomarker

LINC01506 is a long intergenic non-protein coding RNA (lncRNA) that has been identified as a potential drug target or biomarker. It is located on chromosome 6 and encodes a protein with 29 amino acid residues, which is known as LINC01506-AS1.

LINC01506 is a non-coding RNA molecule that is expressed in various tissues and organs, including brain, heart, and muscle. It is characterized by its long length, which allows it to interact with other non-coding RNAs and proteins in the body.

One of the key features of LINC01506 is its ability to interact with the protein known as NLRPase, which is a key regulator of the immune response and plays a role in the development of various diseases, including cancer. NLRPase is a protein that is expressed in various tissues and organs throughout the body and is known for its ability to interact with a wide variety of non-coding RNAs, including LINC01506.

In addition to its interaction with NLRPase, LINC01506 has also been shown to interact with several other non-coding RNAs and proteins that are involved in various cellular processes, including cell division, migration, and stress response. These interactions may have important implications for the function of LINC01506 and its potential as a drug target or biomarker.

One of the key advantages of LINC01506 as a drug target is its ability to interact with a wide variety of proteins, making it a potentially promising target for the development of new drugs. This is because LINC01506 is involved in a wide range of cellular processes that are involved in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. As a result, LINC01506 may be a useful target for the development of new drugs that can treat these conditions.

In addition to its potential as a drug target, LINC01506 may also be a useful biomarker for the diagnosis and monitoring of various diseases. This is because it is expressed in a wide variety of tissues and organs and can be easily detected using techniques such as qRT-PCR or RNA sequencing. As a result, LINC01506 may be a useful tool for the diagnosis and monitoring of various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

Overall, LINC01506 is a long intergenic non-protein coding RNA that has been identified as a potential drug target or biomarker. Its ability to interact with the protein NLRPase and other non-coding RNAs and proteins suggests that it may be a useful target for the development of new drugs for a wide variety of diseases. Additionally, its expression in various tissues and organs makes it a potentially useful biomarker for the diagnosis and monitoring of these diseases. Further research is needed to determine the full potential of LINC01506 as a drug target or biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 1506

The "LINC01506 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01506 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets